OR WAIT null SECS
October 01, 2015
CPhI’s Annual Report discusses the implications of QbD, continuous processing, excipient criticality, and process validation on pharmaceutical manufacturing and predicts a steady shift to continuous manufacturing.
September 02, 2015
Siegfried Schmitt, principal consultant, PAREXEL, discusses how to assure compliance for automated systems.
Worldwide, meetings take place for several reasons, such as to share new findings, learn about novel technologies, discuss international issues, exchange know-hows, and network, to name a few. While each of these reasons has its significant importance, what really matters in scientific inquiry is progress.
Ensuring data integrity involves effort on an individual and global basis.
September 01, 2015
This special issue combines technical articles on leading pharma industry topics and a comprehensive preview of the upcoming CPhI Worldwide trade show
August 17, 2015
*This article is an opinion piece and does not necessarily represent the views of BioPharm International.
August 02, 2015
FDA notes progress in drug development, but cites scientific and funding roadblocks.
August 01, 2015
Within the past few years, key players have left the sterile manufacturing business. Can new technology and investment revitalize this critical market?
July 28, 2015
FDA’s quality metrics draft guidance details the types of data the agency plans to request and the quality metrics it plans to calculate.
July 24, 2015
As more patents make their way through IPRs, the balance of how the pharmaceutical industry selects between IPRs and district court litigation will likely evolve.